Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Flavanones represent a significant subclass of flavonoids, defined chemically by a saturated C-ring and the absence of a double bond between positions 2 and 3 of the flavan skeleton [10, 15]. They are abundant in citrus fruits, such as oranges and grapefruits, and serve as important dietary phytochemicals with diverse biological activities [2, 3]. Although Flavanones are a class of small molecules rather than a specific therapeutic protein target like a receptor or enzyme, they are of high interest in drug discovery due to their ability to modulate various biological systems [1, 5]. Their primary mechanisms of action include the scavenging of reactive oxygen species and the modulation of key signaling kinases and transcription factors, such as NF-κB, MAPK, and Nrf2 [10, 14, 15]. These interactions contribute to their well-documented anti-inflammatory, antioxidant, and potential anti-cancer properties [3, 12, 17]. Clinically, specific flavanones like naringenin and hesperetin are being extensively explored for their roles in managing cardiovascular disease, metabolic syndrome, and neurodegenerative conditions [2, 3, 10]. However, their development as therapeutics is challenged by low oral bioavailability and significant interactions with drug-metabolizing enzymes like Cytochrome P450 and efflux transporters like P-glycoprotein, which can lead to complex drug-drug interactions [10, 16, 18, 19].
Scavenging of reactive oxygen species (ROS), inhibition of pro-inflammatory cytokines, modulation of MAPK and PI3K/Akt signaling pathways, and interaction with nuclear receptors such as ER, LXR, and FXR [10, 13, 14].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Flavanone.